Key result
A history of cancer in patients hospitalized with new onset acute heart failure was associated with a higher risk of in-hospital mortality compared to no cancer (9.3% vs. 6.4%; OR 1.40).
Why the study?
Limited evidence exists regarding outcomes of cancer patients hospitalized with new onset acute heart failure.
Does a history of cancer increase mortality in patients hospitalized with new onset acute heart failure?
Cohort (n=283,144)
Yes
Does a history of cancer increase mortality in patients hospitalized with new onset acute heart failure?
Odds Ratio: 1.4 (95% CI 1.34–1.46)
Absolute Event Rate: 9.3% vs 6.4%
p-value: p=<0.0001
A history of cancer is present in nearly one-fifth of patients hospitalized with new-onset acute heart failure and is associated with significantly higher in-hospital and 1-year mortality.
May warrant closer monitoring in acute HF with cancer history; leaves open whether cancer independently predicts mortality or reflects confounding.
AIMS: Limited evidence exists regarding the outcomes of cancer patients hospitalized with new onset acute heart failure (AHF). We assessed the in-hospital mortality and 1 year outcomes of cancer patients admitted for new onset AHF, taking into account both past and active cancer status as well as cancer site. METHODS: We examined administrative data of adult patients hospitalized with a first episode of AHF from 2003 to 2018 in Lombardy, Italy. Patients were categorized based on their cancer history. The primary endpoint was in-hospital mortality with secondary endpoints including 1 year all-cause mortality and 1 year re-hospitalization for AHF. RESULTS: Among 283 144 patients AHF hospitalizations, 55 145 (19%) involved patients with a history of cancer (60% past cancer, 40% active cancer). Both in-hospital and 1 year mortality rates were higher among cancer patients compared with those without (9.3% vs. 6.4% and 34.9% vs. 22.3%, respectively; P < 0.0001). After adjustment, cancer patients exhibited increased risk of in-hospital mortality [odds ratio (OR) 1.40; 99% confidence interval (CI) 1.34-1.46] and 1 year mortality (HR 1.35; 99% CI 1.32-1.39), particularly among those with lung cancer. Patients with active and past cancer had a similar in-hospital mortality risk (OR 0.99; 99% CI 0.91-1.07) while 1 year mortality risk was higher among those with active cancer (HR 1.26; 99% CI 1.21-1.31). CONCLUSIONS: Cancer is a prevalent comorbidity in patients hospitalized with new onset AHF, and it is associated with a poorer prognosis. Mortality risk appears to vary based on cancer status and type.
No takes yet. Share an insight, caveat, or question.
Marenzi et al. (2024) conducted a cohort in New onset acute heart failure (n=283,144). History of cancer vs. No history of cancer was evaluated on In-hospital mortality (OR 1.40, 95% CI 1.34-1.46, p=<0.0001). A history of cancer in patients hospitalized with new onset acute heart failure was associated with a higher risk of in-hospital mortality compared to no cancer (9.3% vs. 6.4%; OR 1.40).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: